TTI-101
- Generic Name
- TTI-101
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H21NO5S
- CAS Number
- 432001-19-9
- Unique Ingredient Identifier
- KZ3DLD11RQ
- Associated Conditions
- -
- Associated Therapies
- -
Trial of Radiotherapy in Combination with TTI-101 in Patients with Borderline Resectable Pancreatic Cancer
- First Posted Date
- 2023-11-21
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 35
- Registration Number
- NCT06141031
- Locations
- 🇺🇸
University of Colorado, Aurora, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath